Ramani P, Balkwill F R
Imperial Cancer Research Fund Laboratories, London, UK.
Br J Cancer. 1988 Sep;58(3):350-4. doi: 10.1038/bjc.1988.217.
Therapy with human lymphoblastoid interferon HuIFN-alpha(N1), or recombinant human interferon gamma, rHuIFN-gamma, inhibited experimental pulmonary metastases of the human melanoma cell line, DX3-azac, in BALB/c nude mice and significantly prolonged survival. The human IFNs had no effect on nude mouse lung and spleen NK cell activity, lung macrophage activity, haemoglobin or white cell counts. HuIFN-alpha(N1) had no effect on the levels of the IFN induced enzyme 2-5A synthetase in nude mouse lungs although the rHuIFN-gamma caused some elevation. In addition, clearance of radiolabelled DX3-azac cells was identical in control or human IFN treated mice, and there was no histological evidence of an increase in immune effector cells associated with the metastatic lesions in treated mice. Human IFN therapy did not affect the state of differentiation of the melanoma cells in vivo as measured by melanin content, but both IFNs inhibited the development of colonies of DX3-azac cells in vitro. We conclude that in this model system IFNs have direct anti-proliferative effects on metastatic cells.
用人淋巴母细胞干扰素HuIFN-α(N1)或重组人干扰素γ(rHuIFN-γ)进行治疗,可抑制人黑色素瘤细胞系DX3-氮杂胞苷在BALB/c裸鼠体内的实验性肺转移,并显著延长生存期。这两种人干扰素对裸鼠肺和脾的自然杀伤细胞活性、肺巨噬细胞活性、血红蛋白或白细胞计数均无影响。HuIFN-α(N1)对裸鼠肺中干扰素诱导酶2-5A合成酶的水平没有影响,尽管rHuIFN-γ会使其有所升高。此外,在对照小鼠或接受人干扰素治疗的小鼠中,放射性标记的DX3-氮杂胞苷细胞的清除情况相同,并且没有组织学证据表明治疗小鼠中与转移灶相关的免疫效应细胞增加。通过黑色素含量测定,人干扰素治疗对体内黑色素瘤细胞的分化状态没有影响,但两种干扰素在体外均抑制DX3-氮杂胞苷细胞集落的形成。我们得出结论,在该模型系统中,干扰素对转移细胞具有直接的抗增殖作用。